{
  "pmcid": "11343829",
  "sha256": "196fdaa4395cb60098b1f2a3ae88f106f90d1dd47fae7c9604cc9fd7b644a3d0",
  "timestamp_utc": "2025-11-09T23:15:13.946347+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.685314851485149,
    "reading_ease": 32.87181386138619,
    "word_count": 303
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Allopurinol in Neonates with CCHD Undergoing Cardiac Surgery"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Fourteen neonates with prenatal CCHD diagnosis were randomised"
      },
      "Participants": {
        "score": 2,
        "evidence": "Fourteen neonates with prenatal CCHD diagnosis"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised to receive either allopurinol or placebo"
      },
      "Objective": {
        "score": 1,
        "evidence": "investigating the effect of postnatal and perioperative allopurinol on postoperative brain injury"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the pharmacokinetics (PK) of allopurinol and oxypurinol, measured over the preoperative, intraoperative, and postoperative phases."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed by Ace Pharmaceuticals using blocking, and allocation was concealed."
      },
      "Blinding": {
        "score": 3,
        "evidence": "Blinding included outcome assessors, patients, and clinicians."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Fourteen neonates with prenatal CCHD diagnosis were randomised"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "A two-compartment model for allopurinol and a one-compartment model for oxypurinol best described the PK."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "NCT04217421"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 19,
    "max_score": 25
  }
}